Skip to Main Content

Paper Details

Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma.
Haematologica
20
2021
ARI2h, ARI2h cells, ARI2m, ARI2m cells, B, B cell maturation antigen, B-cell maturation antigen, BCMA, CAR, CART, CART cells, MM, Multiple myeloma, TNF, chimeric antigen receptor, hematological B cell malignancies, multiple myeloma, murine, murine CART cells, myeloma, patient, patients, tumor
Author NameAffiliation
Jaume BonetEcole Polytechnique Federale de Lausanne
Narcis Fernandez-FuentesU Science Tech. Universitat de Vic-Universitat Central de Catalunya.
Narcis Fernandez-FuentesU Science Tech. Universitat de Vic-Universitat Central de Catalunya.
  • 1 - 3

Datasets

Release 1.2